Thinking of taking your company public? Get our essential guide to a successful IPO. Download Now

Westicke Partners

Close

ICR Westwicke Blog

The ICR Westwicke Blog is designed to deliver information and insights into the ever-changing world of healthcare communications.

2020 Gives Rise to Another IPO Alternative: Direct Listings

Posted on October 30th, 2020. Posted by

Wall Street - Direct Listings

In the wake of the coronavirus pandemic, the IPO market may never look the same. The swift shift to virtual roadshows, for example, has demonstrated efficiencies that are likely to make digital alternatives stick even after regular business travel resumes. But beyond the operational changes behind preparing a company to go public, the market has seen growing interest in alternatives to the IPO itself.

Continue Reading

How to Make the Most of Virtual Non-Deal Roadshows

Posted on October 8th, 2020. Posted by

Virtual Non-Deal Roadshows

The challenges of functioning successfully in an extended COVID-19 environment have presented many new ways of doing business. This is especially evident for events such as non-deal roadshows (NDRs).

Continue Reading

Things to Know About SPAC Transactions

Posted on September 25th, 2020. Posted by

Info About SPAC Transactions

Over the past several months, interest in special purpose acquisition companies (SPACs) has grown exponentially. SPAC transactions serve as an alternative to traditional IPOs, and while they have existed for many years, they are currently experiencing a resurgence within several industries.

Continue Reading

The Virtual IPO: How IPOs Are Changing

Posted on August 26th, 2020. Posted by

Expert Advice on IPOs

According to some experts, the past several months have created more change in the IPO market than the last 25 to 30 years. In the recent webinar hosted by ICR Capital and Davis Polk, those experts discussed what they’ve seen in the IPO market recently, changes to standard IPO processes, and what’s to come for IPOs during the remainder of the year.

Continue Reading

Biotech IPOs: What to Expect in the Second Half of 2020

Posted on August 6th, 2020. Posted by

Biotech IPOs

For much of the first half of 2020, the coronavirus pandemic ground most business to a halt. Biotech innovation, however, has continued in full force. Even during the turbulent first few months of the year, biotech companies have moved forward with successful IPOs.

The pandemic isn’t over, however, and cases continue to rise in parts of the U.S. What will that mean for IPOs in the second half of the year?

Continue Reading

Should You Proceed With IPO Planning Regardless of Market Conditions?

Posted on April 22nd, 2020. Posted by

Should You Proceed With IPO Planning Regardless of Market Conditions?

In January, we made three predictions about the IPO market in 2020 — but no one could have predicted the current market conditions and business ramifications as a result of the coronavirus pandemic. Companies across the globe have had to change the way they do business, from transitioning to a remote workforce to making changes to their supply chain.

Continue Reading

What to Do After You File Your S-1

Posted on March 12th, 2020. Posted by

S-1 Checklist

During the year (or more) before your company goes public, you’ll be in a constant state of activity, from building relationships with investors, bankers, and sell-side analysts, to engaging in test-the-waters meetings. However, once your S-1 flips public, the U.S. Securities and Exchange Commission (SEC) requires that you wait 15 days before your road show begins. That doesn’t mean you should sit back and relax, though. Use this checklist to maintain your company’s momentum and progress during this time.

Continue Reading

3 Predictions About the IPO Market in 2020

Posted on January 9th, 2020. Posted by

IPO predictions

Financial markets are notoriously difficult to predict. However, armed with decades of Wall Street experience, our investor relations professionals know what can create a strong IPO market — and what can close that window of opportunity.

As we enter the new year, there are several factors to consider for companies that may be considering an IPO. Based on our experience, here are our predictions for the life sciences IPO market in 2020.
Continue Reading

Why You Need an IPO Communications Strategy Well Before the IPO

Posted on October 23rd, 2019. Posted by

IPO Communications Strategy

As the rock ‘n’ roll generation begins settling into their senior years, the “Baby Boomer factor” is wielding its heavy influence on healthcare as it has on other industries. Healthcare spending has grown substantially over the past few decades, and demand will likely remain strong as the number of Americans aged 65 and older will more than double by 2060. At the same time, technologies such as artificial intelligence, blockchain, software-as-a-medical-device and other advances are transforming the healthcare industry and threatening the status quo through rich networks of connection, collaboration, and interdependence.

Continue Reading

Planning a Life Sciences IPO in 2020? Considerations Ahead of an Election Year

Posted on May 22nd, 2019. Posted by

Planning a Life Sciences IPO in 2020

Comprised of former buy- and sell-side professionals, Westwicke’s managing directors can attest to how notoriously difficult financial markets are to predict. One area where there is at least some degree of certainty is the heightened challenge of executing a financing in the midst of an election year, where initial public offering (IPO) activity and appetite for risk tend to diminish, particularly in a politically-charged vertical such as healthcare.

Continue Reading

Have News to Release?

Find out whether you should file a Form 8-K, issue a press release, or do both by using our easy-to-reference chart, “Form 8K vs. Press Release: What’s the Difference?

Our Locations